Novavax, Inc.NVAXNASDAQ
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-46.96%
↓ 163% below average
Average (9y)
74.75%
Historical baseline
Range
High:556.20%
Low:-51.26%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | -46.96% |
| 2023 | -40.30% |
| 2022 | -51.26% |
| 2021 | 239.28% |
| 2020 | 556.20% |
| 2019 | -34.50% |
| 2018 | 3.18% |
| 2017 | -29.21% |
| 2016 | 46.29% |
| 2015 | 104.75% |